Law firms Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business · 9 December 2014 · 2 min read Corporate and M&A Deal watch US firms Baker McKenzie Ropes & Gray One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this category‘The centre of gravity for Southeast Asia’ – why PE investment is making Singapore increasingly attractiveLaw firmsKate Peacock8 May 2026Revolving Doors: US firms lead hiring as White & Case, Cleary, McDermott build across EuropeLaw firmsEliza Winter8 May 2026Trading Places: Paul Weiss and Kirkland grow in Houston, while Gibson Dunn hires S&C appellate co-headLaw firmsKate Peacock5 May 2026Sidley sees exit of four-partner private equity team across NY and LondonLaw firmsWill Lewallen8 May 2026Legal Business Awards 2026: which firms made the shortlist?Law firmsNews Editor7 May 2026Slaughters and Linklaters take the call as Vodafone buys CK Hutchison out for £4.3bnLaw firmsTheresa Hargreaves6 May 2026‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLaw firmsAlex Ryan13 Jan 2025Legal 500 US: Latham tops the charts in new US rankingsLegal 500 dataBarnaby Merrill28 Jun 2024Dealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega dealLaw firmsAlex Ryan15 Jan 2024